...
首页> 外文期刊>Biotechnology and Applied Biochemistry >Changes of protein solutions during storage: a study of albumin pharmaceutical preparations
【24h】

Changes of protein solutions during storage: a study of albumin pharmaceutical preparations

机译:储存过程中蛋白质溶液的变化:白蛋白药物制剂的研究

获取原文
获取原文并翻译 | 示例
           

摘要

During the production of air-filled albumin microspheres,to be used as an ultrasound contrast agent, it was observed that some albumin lots could not be used owing to albumin precipitation. In order to understand the reason for these lot-to-lot variations, 24 lots of 5 % (w/v) human albumin pharmaceutical preparations were analysed. The results revealed that the good albumin lots all contained <0.03 mol of free SH groups per mol of albumin. The precipitation observed with other lots was most probably due to higher amounts of free SH groups. The lower amount of free SH groups in the good lots correlated with: (i) a yellow colour of the solutions and a UV-visible spectrum similar to that observed for non-enzymatic glycosylation; (ii) a decreased fructosamine content; (iii) an increased mobility against the anode in isoelectric focusing; and (iv) an increased truncation of the two N-terminal amino acids. No, or only small, differences were observed for the amounts of albumin dimer, albumin aggregates and protein impurities, and these could not account for the albumin precipitation. The differences observed between the albumin lots were most probably due to varying storage times and/or storage conditions, and incubation experiments revealed changes in all parameters that differed between the good and bad lots. Increasing the storage temperature or exposing the solutions to light resulted in a faster decrease of free SH groups and increase of the yellow colouration.It is likely that at least some of the changes observed were due to reactive degradation products formed from the stabilizer N-acetyl-L-tryptophan. The results presented should also be of interest regarding the storage of monoclonal antibodies and other proteins used in pharmaceuticals.
机译:在生产用作超声造影剂的充气白蛋白微球的过程中,观察到一些白蛋白批次由于白蛋白沉淀而无法使用。为了了解批次间差异的原因,分析了24个批次的5%(w / v)人类白蛋白药物制剂。结果表明,良好的白蛋白批次每摩尔白蛋白都包含<0.03 mol的游离SH基。在其他批次中观察到的沉淀很可能是由于较高数量的游离SH基团引起的。良好批次中较低的游离SH基团含量与以下因素有关:(i)溶液呈黄色,并且可见光谱类似于非酶促糖基化反应; (ii)果糖胺含量降低; (iii)在等电聚焦中相对于阳极的迁移率增加; (iv)两个N-末端氨基酸的截短增加。没有观察到白蛋白二聚体,白蛋白聚集体和蛋白质杂质的数量差异或仅有很小的差异,这些差异不能解释白蛋白的沉淀。在白蛋白批次之间观察到的差异很可能是由于储存时间和/或储存条件的变化,孵育实验揭示了好批次和不良批次之间所有参数的变化。升高储存温度或使溶液暴露于光线下会导致游离SH基团更快地减少并发黄,这至少部分是由于稳定剂N-乙酰形成的反应性降解产物引起的。 -L-色氨酸提出的结果也应与药物中使用的单克隆抗体和其他蛋白质的储存有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号